New Delhi [India], May 5 (ANI): The COVID-19 working group of the National Technical Advisory Group on Immunisation (NTAGI) has recommended allowing the administration of precautionary doses before nine months for those who are travelling abroad according to the receiving country's needs,
New Delhi [India], May 2 (ANI): The COVID-19 working group of the National Technical Advisory Group on Immunisation (NTAGI) will review the data of COVID-19 vaccines for the children aged 5 to 12 years on May 4, said sources on Monday.
New Delhi [India], April 30 (ANI): The National Technical Advisory Group on Immunisation (NTAGI) recommended that the Russian COVID-19 vaccine Sputnik Light which contains the same ingredients as the first dose of Sputnik V can be taken as a precaution dose, said Sources.
New Delhi [India], April 29 (ANI): National Technical Advisory Group on Immunisation (NTAGI) on Friday approved Serum Institute of India's Covovax COVID-19 vaccine for the age group 12-17, said sources.
New Delhi [India], April 11 (ANI): New COVID-19 variants will keep coming, however, the new variants aren't causing severe diseases or increasing the number of cases said Chairman of the COVID-19 working group of India, National Technical Advisory Group on Immunisation (NTAGI), Dr NK Aror
New Delhi [India], April 8 (ANI): With a continuous decline in COVID-19 cases in the country, the Indian Sars-CoV-2 Genomic Consortium (INSACOG) has started surveillance of sewage water at 19 different sites in 15 States to detect the presence of the Sars-CoV-2 virus.
New Delhi [India], March 15 (ANI): The primary focus was immunisation of children with comorbidities but due to the unavailability of data of such children, we have decided to open immunization for all the children between the age group of 12-15 years, said Dr NK Arora, Chairman of COVID-
New Delhi [India], February 15 (ANI): India's third homegrown COVID-19 vaccine Corbevax is safe and offers good immunogenicity and higher antibody levels than some other vector vaccines, said Dr N K Arora, Chairman, India's COVID-19 Working group of National Technical Advisory Group on immun
New Delhi [India], January 11 (ANI): Molnupiravir, an oral antiviral drug used in the treatment of COVID-19 should not be administered to the younger population as it adversely affects their reproductive system, said Dr NK Arora, Chairman of COVID-19 Working Group of National Technical Advis
New Delhi [India], December 26 (ANI): Covaxin has shown that it has a very good immune response in children in trials, Dr NK Arora, Chairman of Covid Task Force working group, NTAGI, said on Sunday.
New Delhi [India], December 14 (ANI): To make a decision regarding a booster dose of the COVID-19 vaccine, the National Technical Advisory Group on Immunisation (NTAGI) is analyzing data of COVID-19 breakthrough infections in India, said sources on Tuesday.
New Delhi [India], October 22 (ANI): With the country achieved the milestone of administering 100 crore COVID-19 vaccine doses, Dr NK Arora, chairman of the COVID-19 Working Group of National Technical Advisory Group on Immunisation (NTAGI) said a social mobilisation campaign must be run so